THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN AND SYNTHESIS A NEW PLGA BASED NANOPARTICLE WITH NANOPARTICLE WITH OPTIMAL PROTEIN-ADJUVANT FORMULATION COMBINING BOTH TARGETING AND CONTROLLED DELIVERY FOR IMMUNIZATION AGAINST HIV.
$300,000
| Recipient | NANOCOMPOSIX, INC. UEI EVQMBF7KC8P3 |
|---|---|
| Award ID | 75N93020C00013 |
| Award amount | $300,000 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Small business |
| Start date | Jun 1, 2020 |
| End date | May 31, 2023 |
| Place of performance | SAN DIEGO, CA |
| Record updated | Jan 27, 2023 |
View the official award record
More awards won by NANOCOMPOSIX, INC.
THE OBJECTIVE IS TO DEVELOP CMV IGG AND IGM LATERAL FLOW ASSAYS REQUIRED TO SUPPORT A LARGE SCALE CMV VACCINATION TRIAL.
Department of Health and Human Services · $1,500,000 · Jul 31, 2019
THE OBJECTIVE OF THIS CONTRACT IS TO GENERATE AN EFFECTIVE HIV VACCINE USING THE TARGETED AND CONTROLLED DELIVERY OF ANTIGENS TO ANTIGEN PRESENTING CELLS (APC). ENGINEERED NANOPARTICLES LOADED WITH MRNA CAPTURED BEHIND PH SENSITIVE POLYMER, TARGETED WITH MANNOSE WILL BE EMPLOYED TO INDUCE A HIV-SPECIFIC AND CELLULAR IMMUNE RESPONSE.
Department of Health and Human Services · $600,000 · Jun 17, 2019
LATERAL FLOW ASSAY DEVICES
Department of Health and Human Services · $300,000 · Sep 28, 2022
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids